Mejia Bright
@judocotton4 · Active 2 years, 11 months ago
The cost-effectiveness associated with TDM along with IM (I’m TDM) within first-line CML treatment method hasn’t yet been recently studied. Aims To ascertain the cost-effectiveness associated with I am TDM for the first-line treating CML in comparison to tyrosine kinase inhibitor merely treatment. Strategies Any lately posted cost-effectiveness […] View
-
Name
Mejia Bright
-
I agree with the terms and conditions
Yes
Achievements
0
Need some help?
Start a live chat session with one of our expert advisors.